Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.6K Sell
690
-38
-5% -$1.8K 0.01% 443
2025
Q4
$32.7K Buy
728
+59
+9% +$2.73K 0.01% 392
2025
Q3
$29.9K Hold
669
0.01% 406
2025
Q2
$32.3K Buy
669
+82
+14% +$3.57K 0.01% 402
2025
Q1
$23.6K Hold
587
0.01% 435
2024
Q4
$26.9K Hold
587
0.01% 445
2024
Q3
$27.5K Buy
587
+58
+11% +$2.65K 0.01% 459
2024
Q2
$22.4K Sell
529
-287
-35% -$12.6K 0.01% 483
2024
Q1
$36.1K Buy
+816
New +$37.2K 0.01% 453
2023
Q4
Sell
-643
Closed -$27.6K 990
2023
Q3
$27.6K Hold
643
0.01% 574
2023
Q2
$30.7K Buy
+643
New +$31K 0.01% 575

Other funds holding QGEN

Park Place Capital's QGEN Position: Q1 2026 in Review

Park Place Capital reduced its Qiagen (QGEN) stake by 5.2% in Q1 2026, selling an estimated $1.8K and leaving 690 shares worth $27.6K. The position accounts for 0.01% of the portfolio, ranked #443.

Park Place Capital first reported a position in QGEN in Q2 2023 and has held it in 11 quarters since. The position peaked at $36.1K in Q1 2024. 343 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

  • Park Place Capital held 690 shares of Qiagen worth $27.6K as of Q1 2026.
  • Park Place Capital sold 38 Qiagen shares in Q1 2026, an estimated $1.8K.
  • Qiagen made up 0.01% of Park Place Capital's portfolio in Q1 2026, its #443 holding.
  • Park Place Capital first reported a position in Qiagen in Q2 2023 and has held it in 11 quarters since.
  • Park Place Capital's Qiagen position peaked at $36.1K in Q1 2024.
  • 343 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on Park Place Capital's 13F filing for Q1 2026, filed 9 Apr 2026.